Canada Pension Plan Investment Board’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Canada Pension Plan Investment Board's AZN Position: Q1 2026 in Review
Canada Pension Plan Investment Board opened a new position in AstraZeneca (AZN) in Q1 2026: 661,545 shares worth $129M. The stake represents 0.08% of the portfolio and ranks #220 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in AZN as recently as Q2 2019.
Canada Pension Plan Investment Board first reported a position in AZN in Q2 2013 and has held it in 17 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Canada Pension Plan Investment Board held 661,545 shares of AstraZeneca worth $129M as of Q1 2026.
- AstraZeneca was a new Canada Pension Plan Investment Board position in Q1 2026.
- AstraZeneca made up 0.08% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #220 holding.
- Canada Pension Plan Investment Board first reported a position in AstraZeneca in Q2 2013 and has held it in 17 quarters since.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.